Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home
Patients & Consumers Health Professionals District Health Boards Pharmaceutical Suppliers

Thu Feb 9 2012 NZST

Search term:

2009 / 05

PHARMAC documents that matched your search:

Prev, Next – Page 1 of 3 (26 documents)

icon

May 2009 Tender Results (6 pages, 112 KB)
2009/05/29
archive, notification

29 May 2009 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 23…

text


icon

Proposal to list Clarithromycin 500 mg tablets. Closed. (2 pages, 57 KB)
2009/05/29
archive, consultation

29 May 2009 Proposal to list Clarithromycin 500 mg tablets PHARMAC is seeking feedback on a proposal to fund clarithromycin 500 mg tablets (Klamycin) on the Pharmaceutical Schedule. In summary, this proposal would result in: • • • Klamycin 500…

text


icon

Proposal to list low molecular weight heparin. Closed. (4 pages, 61 KB)
2009/05/29
archive, consultation

29 May 2009 Proposal to list low molecular weight heparin in the Pharmaceutical Schedule Proposal Summary PHARMAC is seeking feedback on a proposal to list one brand of low molecular weight heparin in Section B of the Pharmaceutical Schedule from…

text


icon

PTAC & Subcommittee Membership (5 pages, 30 KB)
2009/05/29

Subcommittee Analgesic Dr Howard Wilson Dr Jane Thomas Dr Bruce Foggo Dr Geoff Robinson Dr Lindsay Haas Dr Jonathan Adler Dr Rick Acland Dr Ian Hosford General Practitioner / Pharmacologist Paediatric Anaesthetist Palliative Medicine Consultant Chief Medical Officer/Addiction Medicine Neurologist…

text


icon

SA0473 - Imiglucerase (Cerezyme) therapy - entry and exit criteria (6 pages, 113 KB)
2009/05/29
SAForm

Schedule 1: Access criteria for treatment with imiglucerase (Cerezyme). Guidelines for use of imiglucerase. a) The diagnosis of symptomatic type 1 Gaucher disease must have been established by the demonstration of specific deficiency of glucocerebrosidase in leukocytes or cultured skin…

text


icon

Proposal to list pegfilgrastim (Neulastim) on the Discretionary Community Supply list. Closed. (2 pages, 159 KB)
2009/05/28
archive, consultation

28 May 2009 Proposal to list pegfilgrastim (Neulastim) on the Discretionary Community Supply list PHARMAC is seeking feedback on a proposal to list pegfilgrastim on Part IV of Section H of the Pharmaceutical Schedule (Discretionary Community Supply). In summary, this…

text


icon

Voluntary Checklist for Health Consumer Organisations Considering Health Industry Sponsorship (7 pages, 142 KB)
2009/05/28
CAC, resource

CAC Consumer Advisory Committee Voluntary Checklist for Health Consumer Organisations Considering Health Industry Sponsorship Contents Introduction Guiding principles if considering health industry sponsorship Checklist Deciding whether to enter into a relationship Formalising the relationship Making the relationship work Concluding the…

text


icon

Proposal for Mylan risperidone, lithium, quetiapine. Closed. (2 pages, 50 KB)
2009/05/27
archive, consultation

27 May 2009 Proposal for Mylan risperidone, lithium carbonate and quetiapine PHARMAC is seeking feedback on a proposal to fund a new brand of risperidone oral liquid (Risperon), and to amend the terms of listing of the Lithicarb brand of…

text


icon

Therapeutic Group Manager Job Description (4 pages, 52 KB)
2009/05/25
archive, vacancy

POSITION DESCRIPTION POSITION TITLE: THERAPEUTIC GROUP MANAGER Location: Reports to: Date: WELLINGTON MANAGER, FUNDING & PROCUREMENT May 2009 PURPOSE OF THE POSITION The primary purpose of this role is to lead and manage PHARMAC’s processes for pharmaceutical funding and expenditure…

text


icon

Schedule Update - effective 1 June 2009 (37 pages, 440 KB)
2009/05/22
SchedulePublications, update

Pharmaceutical Management Agency Update New Zealand Pharmaceutical Schedule Effective 1 June 2009 Cumulative for May and June 2009. Section H cumulative for April, May and June 2009 Contents 2 Summary of PHARMAC decisions EFFECTIVE 1 JUNE 2009 New listings (page…

text


Prev, Next – Page 1 of 3 (26 documents)

Search tips

Search or Browse

To search for a document enter a search term into the search form and activate the Search button.

Documents may be browsed by date, eg; Today, February, 2012.

Past years can be browsed too...
2011, 2010, 2009, 2008, 2007, 2006, 2005, 2004, 2003, 2002, 2001, 2000, 1999, 1998.

Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg;
Media releases from 2012

Search terms

Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.

Document tags (shown in bolded red below document date) have highest priority when search results are ranked, followed by title, abstract and full text of document (if available). Tags in use include...
AnnualReview, archive, BoardPaper, BusinessPlan, CAC, CACminutes, CCNotifications, ClinNewsletter, consultation, EC, ECForm, EOI, etender, herceptin, inpharmation, leaflet, LetterOfExpectations, media, notification, OIA, OutputAgreement, PatientGuide, policy, poster, PTAC, PTACminutes, PTACSCMinutes, Q&A, release, resource, RFI, RFP, SAForm, SAForms, schedule, ScheduleDispatch, SchedulePublications, SectionH, SOI, tender, update, vacancy, WhatsNew.

Documents with related dates can be browsed through the date component links below the document title.

Remember to group or statements with parentheses if they are beside and statements.

Search examples

consultation
Search for consultations
media and not antibiotics
Search for media related documents that don't mention antibiotics.
(media or consultation) and vaccines
Search for media releases and consultation documents mentioning vaccinations.